Global Blood Cancer Therapeutics Market 2019-2023 | Key Insights and Forecasts | Technavio
LONDON–(BUSINESS WIRE)–#Biotechnology–The global blood cancer therapeutics market is expected to grow by USD 12.63 billion by 2023, according to the…
Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#Biotechnology–The global blood cancer therapeutics market is expected to grow by USD 12.63 billion by 2023, according to the…
– IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer…
Sosei Group Corporationhas partnered up with Takeda to work on novel molecules, including small molecules and biologics, that modulate G protein-coupled receptor (“GPCR”) targets.
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced today that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge…
Breakthrough offering combines the power of machine learning with the transparency of Evaluate’s renowned analytical approach for the most accurate…
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Together global partners, MEDISCA, MEDISCA Network, and LP3 Network are excited to announce that they will be hosting…
Consultation and resources available free-of-charge to local community SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will…
Consultation and resources available free-of-charge to local community SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) reported that Pfizer Inc. (NYSE: PFE) announced today that the Phase 3 Rivipansel (GMI-1070):…
U.S. market not affected TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced that it will voluntarily replace certain NATESTO®…